期刊文献+

早期使用替罗非班及抽吸导管对减少AMI急诊PCI无复流的疗效观察 被引量:13

Clinical observation on reducing no-reflow after PCI treatment by early using Tirofiban and suction catheter in AMI patients
下载PDF
导出
摘要 目的研究早期使用替罗非班及抽吸导管对减少急性心肌梗死(AMI)急诊经皮冠状动脉介入治疗(PCI)无复流的疗效。方法将76例入选患者分为A组(38例)和B组(38例),A组在导丝进入后即冠状动脉使用替罗非班血栓导管抽吸,B组于球囊扩张后发现血栓负荷重再应用替罗非班血栓导管抽吸。另选同期38例用药盐酸替罗非班后再做球囊扩张的AMI患者38例作为C组。观察不同治疗方案对无复流和慢血流、心血管不良事件、出血性并发症等的发生情况的影响。结果 A组与其他两组无复流和慢血流情况比较差异有统计学意义(P<0.05);C组和B组比较差异无统计学意义(P>0.05)。3组在经过不同的手术处理后,其出血性并发症发生情况差异无统计学意义(P>0.05)。A组和B、C组的心血管不良事件发生情况差异有统计学意义(P<0.05),但C组和B组比较差异无统计学意义(P>0.05)。结论 3种治疗方案对减少AMI急诊PCI无复流均有一定的作用,但早期使用替罗非班及抽吸导管在对减少AMI急诊PCI无复流有显著的临床意义。该研究为减少AMI急诊PCI无复流提供了一种有效的治疗方案。 Objective To study the effect of reducing no-reflow after PCI treatment by early using Tirofiban and suction catheter in AMI patients .Methods 76 cases of patients were divided into group A (38 cases) and group B(38 cases) .The group A began to use Tirofiban with suction catheter to aspiration after coronary guidewire entering ,the suction were used in group B when the thrombus burden became exacerbation after balloon dilation .In addition ,chosen 38 cases of AMI patients treated with Tirofiban af-ter balloon dilation as group C .The influence of different treatment options to no-reflow and slow blood flow ,cardiovascular adverse events and the incidence of bleeding were observed .Results Group A compared with other two groups ,the no-reflow and slow flow rate had statistically significant differences (P〈 0 .05) ,but there was no statistically significant differencebetween group B and group C(P〉0 .05) .After three different surgical treatments ,the incidence of bleeding complications had no significant difference (P〉0 .05 .The occurrence of adverse cardiovascular events had statistically significant between A group and C (P〈0 .05) ,but there was no statistically significant difference between group B and group C (P〈0 .05) .Conclusion Three kinds of treatment all have certain effect to reduce no-reflow in emergency PCI of AMI ,but early use of tirofiban with suction catheter in treatment of emergen-cy treatment has great clinical significance to reduce no-reflow .This study provides an effective treatment plan to reduce no-reflow in PCI for AMI .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第20期2598-2599,2602,共3页 Chongqing medicine
关键词 替罗非班 抽吸导管 经皮冠状动脉介入治疗 急性心肌梗死 tirofiban suction catheter percutaneous coronary intervention acute myocardial infarction
  • 相关文献

参考文献12

二级参考文献98

共引文献86

同被引文献127

  • 1寇玲,傅思惟,刘建根,慕博,李淑梅.不同剂量盐酸替罗非班联合PCI治疗老年急性冠脉综合征合并糖尿病患者的有效性与安全性[J].中国老年学杂志,2014,34(3):579-581. 被引量:19
  • 2王云川,常学锋,刘国辉,陶贵周.SYNTAX评分对急性心肌梗死患者急诊PCI术后无复流现象的预测价值[J].中国老年学杂志,2014,34(1):39-42. 被引量:16
  • 3朱巧洪,曾庆思,孙翀鹏,林翰菲,岑人丽,张超亮,刘莉.服用硝酸甘油对多层螺旋CT冠状动脉成像的影响[J].中华放射学杂志,2007,41(8):809-812. 被引量:24
  • 4Victor Hugo Roa-Castro, Ervin Molina-Bello, Hector Valenzuela- Su6rez,et al. Survival after Left Ventricular Free Wall Rupture in an Elderly Woman with Acute Myocardial Infarction Treated Only Medi- cally[J]..Case Reports in Vascular Medicine, 2012,4(56):1123-1126.
  • 5Vladimir Manchurov, Nadezda Ryazankina, Tatyana Khmara.et al.Remote ischemie preconditioning and endothelial function in patients with a- cute myocardial infarction and primary PCI[J]..The American Journal of Medicine, 2014,36(23):2235-2238.
  • 6Rezkalla SH, Kloner RA. Coronary ncreflow phenomenon: from the experimental laboratory to the cardiac catheteriza- tion laboratory[J]. Catheter Cardiovase Interv, 2008,72 (7): 950-957.
  • 7Niccoli G, Burzotta F, Galiuto L, et al. Myocardial no-reflow in humans[J]. J Am Coll Cardiol, 2009,54(4) : 281-292.
  • 8Su Q,Li L,Liu YC. Short-term effect of verapamil on cor- onary no-reflow associated with percutaneous coronary in- tervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized con- trolled trials[J]. Clin Cardiol,2013,36(8) :E11-16.
  • 9Qin T, Xie L, Chen MH. Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-refiow phenomenon[J]. BMC Cardiovasc Disord, 2013,13 : 68.
  • 10Zhao SJ,Qi GX,Tian W, et al. Effect of intraeoronary ni- troprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analy- sis[J]. J Interv Cardiol, 2014,27 (4) : 356-364.

引证文献13

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部